Ruti Aga's Six Years: Two for the Drug, Four for the Paper
**मुख्य उत्तर:** रुति अगा को छह साल का प्रतिबंध मिथाइलप्रेडनिसोलोन के लिए नहीं, बल्कि फ़र्ज़ी प्रिस्क्रिप्शन के लिए मिला। एथलेटिक्स इंटीग्रिटी यूनिट ने पदार्थ मिलने पर दो साल और छेड़छाड़ पर चार साल दिया; प्रतिबंध 10 सितंबर से बैकडेटेड है। **मुख्य तथ्य:** - रुति अगा (इथियोपिया, 32) ने मार्च में चीन में हाफ मैराथन जीती, जिसके बाद लिए नमूने में मिथाइलप्रेडनिसोलोन पाया गया। - मिथाइलप्रेडनिसोलोन ग्लूकोकोर्टिकॉइड (WADA वर्ग S9) है, एनाबॉलिक स्टेरॉयड नहीं; यह केवल प्रतियोगिता के दौरान प्रतिबंधित है। - सज़ा का गणित: उपस्थिति के लिए दो साल जमा छेड़छाड़ के लिए चार साल, कुल छह साल, 10 सितंबर से लागू। - प्रिस्क्रिप्शन पर लिखा क्लिनिक अस्तित्व में नहीं था; लिखने वाला परिवार का सदस्य था, जिसका मेडिकल रजिस्ट्रेशन नहीं था। - विज्ञप्ति में रेस का समय, पर्सनल बेस्ट या नतीजे रद्द होने का दायरा नहीं बताया गया। **स्रोत:** एथलेटिक्स इंटीग्रिटी यूनिट (AIU) की सार्वजनिक विज्ञप्ति; प्रतिबंध प्रारंभ तिथि 10 सितंबर, अनंतिम निलंबन से बैकडेटेड। **संबंधित प्रश्न-उत्तर:** प्रश्न: क्या उनका 2019 टोक्यो मैराथन ख़िताब रद्द हुआ? उत्तर: विज्ञप्ति किसी पुराने नतीजे को रद्द नहीं करती, लेकिन रद्दीकरण का दायरा भी स्पष्ट नहीं करती। प्रश्न: छह साल की सज़ा किन दो हिस्सों से बनी? उत्तर: दो साल प्रतिबंधित पदार्थ की उपस्थिति के लिए और चार साल फ़र्ज़ी दस्तावेज़ व भ्रामक बयान के लिए। प्रश्न: क्या अपील संभव है? उत्तर: CAS में अपील की खिड़की आम तौर पर तर्कसंगत निर्णय से लगभग 21 दिन होती है, पर दस्तावेज़-आधारित फ़ैसला पलटना कठिन है।
Six years. That is the one number in the Athletics Integrity Unit (AIU) statement that is fully verified. Everything else — the time of that March half marathon in China, the name of the race, the year the ban expires, whether the result from that race has been annulled — is simply not in the statement.
What is there: Ruti Aga, Ethiopia, 32. Two years for the presence of a substance. Four years for a forged prescription. Add it up — six. The ban runs from 10 September, backdated to the provisional suspension.
Let me show you the receipts before I show you the conclusion. Receipt one: one-third of the six years came from the drug she took, and two-thirds from the piece of paper she had manufactured. This is not a doping story. It is a document-verification story.
Aga's name is remembered by the people who count Major marathon entry lists. She won the 2026 Tokyo Marathon. She has three second-place finishes at World Marathon Majors. She belongs to what I call the 2:18–2:20 class — far from the world record, comfortably above the tier where most elite marathons are actually run. My own files put her personal best in the 2:18s, but that number does not appear in the AIU statement, so I will not smuggle it into the ledger. In 2026, when I wrote a scraper against 1,400 state-meet result PDFs, I learned that missing data is a subject in itself — who did not publish, what was not measured, and why. This statement has to be read the same way.

The facts: a sample taken after she won a half marathon in China in March returned methylprednisolone. Her explanation was that the drug was taken to treat a knee injury. That claim is not hollow. Intra-articular injections for knee inflammation are standard sports-medicine practice in distance runners. But real medicine requires real paperwork, and that is where the story turns.
The AIU investigation broke into three stages. One: the clinic named on the prescription did not exist. Two: the person who wrote it was a family member with no medical registration. Three: that person claimed to have used an old prescription pad from a former workplace, and the clinic in question explicitly disowned the claim.
Three independent verification failures. This is not a filing error. It is the signature of an athlete operating without a credentialed team physician.

Now the part almost all of the coverage got wrong. Methylprednisolone is a glucocorticoid, WADA Prohibited List class S9. Anabolic steroids are class S1. The difference is not cosmetic. S9 glucocorticoids are prohibited in-competition only, by injection, oral or rectal route. A legitimate knee injection out of competition is entirely legal. A violation exists only if residues are present in an in-competition sample.
Which means Aga had a defence that could have worked: route, timing and medical necessity. Even without a Therapeutic Use Exemption, that argument was available. But it demands paperwork — a real clinic, a real doctor, real dates. And she manufactured the one document that was supposed to save her.
Two plus four. That arithmetic is worth reading too. The two-year figure is a conclusion in itself — it is the standard sanction for a Specified Substance, and it tells us the panel rejected the no-significant-fault mitigation that would have cut it. Had that mitigation been accepted, two years could have fallen anywhere between zero and two. The four-year tampering sanction is the Code standard, but here it came not from a document alone but from statements made in interview.
Which opens an inversion any lawyer will seize on: forged paperwork is itself evidence of concealment intent, yet it did not escalate the presence sanction. The panel kept the two accounts separate. The spreadsheet was clean. The story was not.
I read this case less as an anti-doping story and more as a labour-market story. For Ethiopian and Kenyan marathoners, the real market between Majors is the Asian label-race circuit — appearance fees, low risk, low profile. China's half-marathon circuit sits in that tier. The trouble is that the races paying the most money are now also the AIU's most productive testing ground. The fee economy and the testing economy are colliding in the same race.
And the knee, which is the true entry point of the whole case. Chronic knee pathology is a known load-bearing failure in high-volume marathoners. Hers reads as years old rather than an acute March event, because a single lapse does not travel all the way to manufacturing a prescription. The pressure to mask pain is tied to appearance-fee income, glucocorticoids are the cheapest and most available tool, and the surrounding medical network is informal. The forged paper is the end of that process, not the start.

The age math is unforgiving. Six years at 32 means a return at 38. Ethiopian women's marathon depth is such that a 2:18 performer is not automatically selectable; a 38-year-old with a doping record certainly is not. The 2026 Tokyo title does not disappear — the violation is anchored to a later race, and the statement annuls nothing. It also does not say what will be annulled.
This is where I hit the inconsistency I opened the statement to find. On the day the news broke, half the headlines carried the word steroid. That is wrong, and the error is not minor. It costs twice. First, calling methylprednisolone an anabolic steroid files this case in a family it does not belong to, and invites comparisons that should not be made. Second, it makes invisible the defence that actually existed. The reader never gets to learn that the weight of the sanction came from paper, not pharmacology.
One more thing I will not do: claim that winning a race tells us anything about form. It does not. The statement gives no mark from that March race, no field depth, no splits. The win tells us only that an elite field was assembled and an in-competition test was conducted. I went looking for a trend and found a hole. There is no data here. That is the finding.
Proportionality stays open. Six years for a substance with no proven endurance benefit will be quoted by both sides — as proof of AIU rigour and as proof of uneven enforcement against African road runners. Neither side is wholly wrong. Both are incomplete.
Three things to watch. First, whether the March result and its prize money are formally annulled, as standard practice implies, and whether that is announced separately. Second, whether the AIU ever names the agent or management that accepted or suggested the document; the statement names only a family member. Third, the CAS appeal window, typically about 21 days from the reasoned decision — document-based findings are hard to overturn, but the window is open.
When it closes, three things survive in the record: a 2026 Tokyo title, three Major second places, and a sanction whose heavier half was made of paper rather than chemistry. Everything else — the time, the form, the scope of disqualification — remains missing in exactly the way Indian state-meet splits were missing from 2026 to 2026.
